These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 9731196)

  • 1. Marked enhancement in the reductive dehalogenation of hexachloroethane by a Thr319Ala mutation of cytochrome P450 1A2.
    Yanagita K; Sagami I; Daff S; Shimizu T
    Biochem Biophys Res Commun; 1998 Aug; 249(3):678-82. PubMed ID: 9731196
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distal site and surface mutations of cytochrome P450 1A2 markedly enhance dehalogenation of chlorinated hydrocarbons.
    Yanagita K; Sagami I; Shimizu T
    Arch Biochem Biophys; 1997 Oct; 346(2):269-76. PubMed ID: 9343374
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Catalytic reductive dehalogenation of hexachloroethane by molecular variants of cytochrome P450cam (CYP101).
    Walsh ME; Kyritsis P; Eady NA; Hill HA; Wong LL
    Eur J Biochem; 2000 Sep; 267(18):5815-20. PubMed ID: 10971594
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heterologous expression and characterization of wild-type human cytochrome P450 1A2 without conventional N-terminal modification in Escherichia coli.
    Kim DH; Kim KH; Isin EM; Guengerich FP; Chae HZ; Ahn T; Yun CH
    Protein Expr Purif; 2008 Feb; 57(2):188-200. PubMed ID: 18032064
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of reciprocal active site mutations in human cytochromes P450 1A1 and 1A2 on alkoxyresorufin metabolism.
    Liu J; Ericksen SS; Sivaneri M; Besspiata D; Fisher CW; Szklarz GD
    Arch Biochem Biophys; 2004 Apr; 424(1):33-43. PubMed ID: 15019834
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rate-determining steps in phenacetin oxidations by human cytochrome P450 1A2 and selected mutants.
    Yun CH; Miller GP; Guengerich FP
    Biochemistry; 2000 Sep; 39(37):11319-29. PubMed ID: 10985777
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Marked effects of alcohols and imidazoles on the cumyl hydroperoxide reaction with the wild-type cytochrome P450 1A2.
    Sato H; Shimizu T
    Arch Biochem Biophys; 1995 Sep; 322(1):277-83. PubMed ID: 7574687
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selection and characterization of human cytochrome P450 1A2 mutants with altered catalytic properties.
    Parikh A; Josephy PD; Guengerich FP
    Biochemistry; 1999 Apr; 38(17):5283-9. PubMed ID: 10220313
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutation of a strictly conserved, active-site residue alters substrate specificity and cofactor biogenesis in a copper amine oxidase.
    Hevel JM; Mills SA; Klinman JP
    Biochemistry; 1999 Mar; 38(12):3683-93. PubMed ID: 10090756
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oxidations of p-alkoxyacylanilides catalyzed by human cytochrome P450 1A2: structure-activity relationships and simulation of rate constants of individual steps in catalysis.
    Yun CH; Miller GP; Guengerich FP
    Biochemistry; 2001 Apr; 40(14):4521-30. PubMed ID: 11284709
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Electron transfer in flavocytochrome P450 BM3: kinetics of flavin reduction and oxidation, the role of cysteine 999, and relationships with mammalian cytochrome P450 reductase.
    Roitel O; Scrutton NS; Munro AW
    Biochemistry; 2003 Sep; 42(36):10809-21. PubMed ID: 12962506
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Six novel nonsynonymous CYP1A2 gene polymorphisms: catalytic activities of the naturally occurring variant enzymes.
    Murayama N; Soyama A; Saito Y; Nakajima Y; Komamura K; Ueno K; Kamakura S; Kitakaze M; Kimura H; Goto Y; Saitoh O; Katoh M; Ohnuma T; Kawai M; Sugai K; Ohtsuki T; Suzuki C; Minami N; Ozawa S; Sawada J
    J Pharmacol Exp Ther; 2004 Jan; 308(1):300-6. PubMed ID: 14563787
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dechlorination of halocarbons by microsomes and vesicular reconstituted cytochrome P-450 systems under reductive conditions.
    Salmon AG; Nash JA; Walklin CM; Freedman RB
    Br J Ind Med; 1985 May; 42(5):305-11. PubMed ID: 3986141
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interaction of Angeli's salt with cytochrome P450 1A2 distal mutants: an optical absorption spectral study.
    Shibata Y; Sato H; Sagami I; Shimizu T
    Biochim Biophys Acta; 1997 Nov; 1343(1):67-75. PubMed ID: 9428660
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rate-limiting steps in oxidations catalyzed by rabbit cytochrome P450 1A2.
    Guengerich FP; Krauser JA; Johnson WW
    Biochemistry; 2004 Aug; 43(33):10775-88. PubMed ID: 15311939
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kinetic deuterium isotope effects for 7-alkoxycoumarin O-dealkylation reactions catalyzed by human cytochromes P450 and in liver microsomes. Rate-limiting C-H bond breaking in cytochrome P450 1A2 substrate oxidation.
    Kim KH; Isin EM; Yun CH; Kim DH; Guengerich FP
    FEBS J; 2006 May; 273(10):2223-31. PubMed ID: 16649998
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence that serine 304 is not a key ligand-binding residue in the active site of cytochrome P450 2D6.
    Ellis SW; Hayhurst GP; Lightfoot T; Smith G; Harlow J; Rowland-Yeo K; Larsson C; Mahling J; Lim CK; Wolf CR; Blackburn MG; Lennard MS; Tucker GT
    Biochem J; 2000 Feb; 345 Pt 3(Pt 3):565-71. PubMed ID: 10642515
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolism of polyhalogenated compounds by a genetically engineered bacterium.
    Wackett LP; Sadowsky MJ; Newman LM; Hur HG; Li S
    Nature; 1994 Apr; 368(6472):627-9. PubMed ID: 8145847
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Natural attenuation of chloroethenes: identification of sequential reductive/oxidative biodegradation by microcosm studies.
    Schmidt KR; Tiehm A
    Water Sci Technol; 2008; 58(5):1137-45. PubMed ID: 18824815
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of N-terminal modification of recombinant human cytochrome P450 1A2 on catalytic activity.
    Kim HJ; Lee SB; Guengerich FP; Park YI; Dong MS
    Xenobiotica; 2007 Apr; 37(4):356-65. PubMed ID: 17455110
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.